“Avamed Synergy presents one of its innovation projects in several sector events”.

The company's team has unveiled BARIATRIC AI, a project funded and approved by the Valencian Institute of Competitiveness and Innovation (IVACE+i)

Last week, the biotech company Avamed Synergy was present at two events in the biomedical and health sector: the biomedical conferences of the University of Alicante and the CV+i Health Day organized by BIOVAL. These events have offered a space for the exchange of knowledge, the presentation of technological advances both at business and student level, promoting the exploration of new opportunities.

On February 6, the day “Surgical Planning” was held at the Polytechnic School (EPS) of the University of Alicante (UA), where students of the degree and master's degree in Biomedical Engineering presented their revolutionary proposals in the field demonstrating a high level of research and involvement. From improved techniques for treatments to new generation devices for improved diagnostics.

On the other hand, last Tuesday, February 11, part of the team went to Valencia on the occasion of CV+i Health Day. Organized at BIOHUB by BIOVAL, an association of companies and entities that make up the Bio cluster of the Valencian Community, the meeting focused on topics in areas such as personalized medicine, diagnostics, advanced therapies and ICT in health.

In both projects Avamed Synergy presented one of the projects it is working on, called Bariatric AI. Its purpose is to study and test the efficacy of a new non-invasive preoperative technique to measure the small bowel loops in Roux-en-Y gastric bypass (RYGB) bariatric surgery, allowing the reduction of costs and risks of the surgical procedure by improving the accuracy in the calculation of several orders of magnitude.

These events reaffirmed Avamed Synergy's commitment to the promotion of new generations, where collaboration is essential in order to develop new cutting-edge advances. Avamed Synergy's presence at these meetings reaffirms its commitment to the development and application of innovative biotechnological solutions that contribute to the growth of the sector.